Pharmamel
Barcelona, Spain· Est. 2013
Pharmamel Drug Discovery is a leader in biotechnology focused on innovative melatonin therapies for critical conditions such as sepsis. Explore our research, clinical trials, and investment opportunities in revolutionary treatments.
Private Company
Total funding raised: $12.5M
About
Pharmamel Drug Discovery is a leader in biotechnology focused on innovative melatonin therapies for critical conditions such as sepsis. Explore our research, clinical trials, and investment opportunities in revolutionary treatments.
Small Molecules
Funding History
2Total raised:$12.5M
Series A$10MNov 15, 2022
Seed$2.5MJun 15, 2021